Danilo Menichelli

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet

Daniele Pastori, Roberto Carnevale, Cristina Nocella et al. · Journal of the American Heart Association · 2017 · 178 citations · Full text

Life Sciences, Cardiology, Nutritional Sciences +17

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events

Daniele Pastori, Pasquale Pignatelli, Danilo Menichelli et al. · Mayo Clinic Proceedings · 2018 · 118 citations

Medicine, Cardiology, Internal Medicine +16

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation

Daniele Pastori, Pasquale Pignatelli, Alessio Farcomeni et al. · Journal of the American Heart Association · 2016 · 91 citations · Full text

Medicine, Cardiology, Aging +16

Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study

Daniele Pastori, A Marang, Arnaud Bisson et al. · Cancer · 2021 · 88 citations · Full text

Medicine, Cardiology, Oncology +17